Kangmei Pharma | 600518 - 税前利润



金融业
股票价格
CNY
资产
CNY 13.07B
现金及等价物
CNY 1.23B
销售成本
CNY 961.15M
流动资产
CNY 6.66B
流动负债
CNY 5.1B
债务
CNY 173.71M
EBIT
CNY -35.26M
EBITDA
CNY -12.72M
员工
6.37K
EPS每股收益
CNY 0.01
股本和储备
CNY 7.83B
销售毛利
CNY 238.34M
债务利息支出
CNY 1.82M
利息收入
CNY 2.44M
贷款资金
CNY 67.35M
市值
CNY 18.72B
净收入
CNY 52.6M
营业费用
CNY 1.22B
营业利润
CNY -35.26M
普通股股本
CNY 13.83B
PE价格收益
1.11K
税前利润
CNY -14.01M
销售收入
CNY 1.19B
销售和管理费用
CNY 253.72M
股票
CNY 2.38B
贸易债权人
CNY 2.27B
应收帐款人
CNY 2.86B


税前利润 更改 日
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Genomma Lab Internacional MXN 534.73M 109.37M 2026-06
Hypermarcas BRL 276.14M 163.07M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Jiangsu Hengrui CNY 2.4B 161.31M 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Moderna USD -1.33B 535M 2026-03
Organon & Co USD 183M 30M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Sh Fosun Pharma CNY 1.36B 82.9M 2026-03
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -247.3M 95.7M 2026-03
Wuxi Apptec CNY 7.91B 2.3B 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03